| Item type |
デフォルトアイテムタイプ（シンプル）(1) |
| 公開日 |
2025-07-03 |
| タイトル |
|
|
タイトル |
ADVERSE DRUG EVENT REPORTS ASSOCIATED WITH SUICIDERELATED BEHAVIOR BEFORE AND AFTER THE CORONAVIRUS DISEASE 2019 PANDEMIC : DATABASE RESEARCH |
|
言語 |
en |
| 作成者 |
Shotaro, Kato
Kyoko, Nomura
Katsuya, Sasaki
Yoshihiro, Minamiya
|
| アクセス権 |
|
|
アクセス権 |
open access |
|
アクセス権URI |
http://purl.org/coar/access_right/c_abf2 |
| 主題 |
|
|
言語 |
en |
|
主題Scheme |
Other |
|
主題 |
COVID-19 |
| 主題 |
|
|
言語 |
en |
|
主題Scheme |
Other |
|
主題 |
suicide |
| 主題 |
|
|
言語 |
en |
|
主題Scheme |
Other |
|
主題 |
antidepressant |
| 主題 |
|
|
言語 |
en |
|
主題Scheme |
Other |
|
主題 |
adverse event |
| 主題 |
|
|
言語 |
en |
|
主題Scheme |
Other |
|
主題 |
database |
| 内容記述 |
|
|
内容記述タイプ |
Abstract |
|
内容記述 |
The purpose of this study is to identify any trend of a signal of five drug categories associated with suicide-related behaviors before and after the coronavirus disease 2019 (COVID-19) pandemic. We used the Japanese Adverse Drug Event Report database before and after the COVID-19 pandemic. The reporting odds ratio (ROR) was used for signal detection to assess whether a particular drug category was more likely to be a suspected drug for suicide-related behavior than for other adverse events. For each drug category, adjusted RORs, adjusted for age and sex, were calculated every 3 months, and trends were observed. The most frequently suspected drug category was antidepressants (n=442, 22%). The adjusted ROR (95% confidence interval) of suicide-related behavior for antidepressants was 17.4 (11.1-27.1) in the early period before the COVID-19 pandemic (April to June 2018), but it gradually increased to 86.1 (47.9-155.0) after 2 years of the COVID-19 pandemic (January to March 2022). In conclusion, only antidepressants showed an upward signal of suicide-related behavior after the COVID-19 pandemic ; during natural disasters such as the COVID-19 pandemic, attention should be paid to suicide-related behavior in patients taking antidepressants. |
|
言語 |
en |
| 出版者 |
|
|
出版者 |
Akita Medical Society |
|
言語 |
en |
| 言語 |
|
|
言語 |
eng |
| 資源タイプ |
|
|
資源タイプ識別子（シンプル） |
http://purl.org/coar/resource_type/c_6501 |
|
資源タイプ（シンプル） |
journal article |
| 出版タイプ |
|
|
出版タイプ |
VoR |
|
出版タイプResource |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| ID登録 |
|
|
ID登録 |
10.20569/0002001683 |
|
ID登録タイプ |
JaLC |
| 収録物識別子 |
|
|
収録物識別子タイプ |
PISSN |
|
収録物識別子 |
0386-6106 |
| 収録物識別子 |
|
|
収録物識別子タイプ |
NCID |
|
収録物識別子 |
AN00009294 |
| 書誌情報 |
en : Akita journal of medicine
ja : 秋田医学
巻 50,
号 3/4,
p. 87-96,
発行日 2024-03-29
|
akitai50_3_4(87).pdf (753.6 KB)
